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The antiarrhythmic effects of potassium canrenoate were examined under in vivo and in vitro conditions. In the 
pentobarbital anesthetized dog, ventricular tachycardia was produced by the i.v. administration of ouabain, 64.4 + 
3.7 ug/kg. Potassium canrenoate was administered in increments of 10 mg/kg until a total dose of 30 mg/kg had 
been achieved. 1 animal developed ventricular fibrillation and in the remaining 7 dogs, the ouabain-induced ectopic 
focus was not suppressed. However, in 3 dogs, a sinus or junctional tachycardia occurred after potassium canrenoate 
was administered and the rates exceeded that of the ventricular focus. Stimulation of the distal right vagus, however, 
resulted in a suppression of the supraventricular rhythm and a reappearance of the ventricular ectopic focus. In the 
rabbit perfused isolated heart, potassium canrenoate (10 -3 M) failed to prevent or reverse acetylstrophanthidin- 
induced arrhythmias. It is concluded that potassium canrenoate fails to suppress or reverse the cardiotoxic effects of 
digitalis in the intact dog heart or in isolated heart muscle preparations. In addition, sodium canrenoate does not 








Potassium canrenoate [soldactone, or potassium 
3-(3-oxo- 17/3-hydroxy-4,6-androstadien-17a-yl) pro- 
panoate],  a diuretic which specifically antagonizes 
aldosterone, has been reported to be effective in pre- 
venting and in terminating experimentally induced 
digitalis arrhythmias (Yeh and Lazzara, 1971; Yeh et 
al., 1971; Yeh and Sung, 1972; Yeh et al., 1972). 
Yeh and Lazzara (1971) reported that potassium can- 
renoate in a concentration of 5 X 10 -5 restored the 
resting membrane potential, the action potential over- 
shoot, dV/dt, and excitability in canine Purkinje 
fibers intoxicated with ouabain. Potassium canreno- 
ate (0.5 mEq, i.v.) was reported to successfully abol- 
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ish ouabain-induced ventricular tachycardia in 6 of 11 
dogs (Yeh and Sung, 1972). All potassium canrenoate 
conversions took place within one minute after the 
intravenous administration of the drug and were 
noted to be an 'all or none phenomenon '  and the 
conversion was said to be 'permanent ' .  The observa- 
tions in the intact dog and upon isolated Purkinje 
fiber preparations were interpreted as suggesting that 
potassium canrenoate was a specific antagonist to the 
electrophysiological effects of digitalis on the cardiac 
cell membrane (Yeh and Lazzara, 1971); a conclusion 
that was supported by the inability of potassium can- 
renoate to reverse arrhythmias secondary to acute 
coronary artery ligation or to catecholamines (Yeh et 
al., 1972 b). 
The present study was undertaken in an effort to 
further explore the antiarrhythmic properties of po- 
tassium canrenoate. The results of this investigation 
have led to the conclusion that potassium canrenoate 
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does not possess a specific antiarrhythmic effect 
against digitalis-induced cardiac rhythm disturbances 
and that previously reported success with potassium 
canrenoate might have been misinterpreted due to the 
ability of the drug to enhance sinus and/or junctional 
pacemaker activity in the digitalis intoxicated heart. 
2. Materials and methods 
2.1. Ouabain-induced arrhythmias in the anesthetized 
dog 
Male mongrel dogs (8.0-12.0 kg) were anesthe- 
tized with pentobarbital sodium, 30 mg/kg, i.v. Blood 
pressure was measured from the left femoral artery 
with a Statham transducer. All drugs were adminis- 
tered into the cannulated left external jugular vein. 
The right vagus nerve was sectioned and its distal end 
was stimulated with 1.0 msec square-wave stimuli at a 
frequency of 20 -40  cps at 8.0-10.0 V. 
Ventricular tachycardia was induced by the admin- 
istration of ouabain, 40/ag/kg i.v., followed in 30 min 
by 20/ag/kg and every 15 min thereafter by an addi- 
tional 10/~g/kg until ventricular tachycardia devel- 
oped (Lucchesi and Hardman, 1961). 
The criteria used to determine antiarrhythmic ac- 
tivity were: (1) reversion to normal sinus rhythm for 
a period of not less than 30 min and (2) the failure of 
right vagal stimulation to expose automatic ectopic 
ventricular activity during the period of vagal-induced 
sino-atrial arrest. 
Lead II electrocardiograms were monitored con- 
tinuously on an oscilloscope and all recordings were 
made on a Grass model 7 polygraph. 
2.2. A cetylstrophanthidin-indueed arrhythmias in the 
rabbit isolated heart 
The rabbit isolated heart was perfused according 
to the Langendorff method. Male rabbits (New Zea- 
land strain), 1.8-2.0 kg in weight were killed by a 
cervical dislocation and their hearts were removed 
quickly. The perfusion solution was of the following 
composition, expressed as mmoles/l: NaC1 171.1, KC1 
2.8, CaCI2"2H20 2.0, MgC12"6H20 2.1, dextrose 
10.0, and THAM buffer, 4.1. The final solution was 
adjusted to a pH of 7.4 by the addition of 1 N HC1. 
The heart was enclosed in a double-walled glass cham- 
ber; the heart and perfusion medium were maintained 
at a temperature of 30°C. The perfusion solution was 
recycled and oxygenated by passing 100% oxygen 
into the reservoir containing the perfusion solution. 
Electrocardiographic recordings were made on a 
Beck-Lee electrocardiograph and were monitored 
continuously on an oscilloscope. 
Arrhythmias were produced in the isolated heart 
through the use of acetylstrophanthidin added to the 
reservoir in a concentration of 640/ag/1 which re- 
suited in a rhythm disturbance within 2 -5  min. The 
arrhythmia was characterized as a nodal tachycardia 
or nodal (junctional) rhythm with retrograde P-wave 
conduction. Longer periods of exposure to acetyl- 
strophanthidin resulted in multifocal ventricular tach- 
ycardia and ventricular fibrillation. 
The time required for the appearance of nodal 
tachycardia or nodal rhythm (latent period) after the 
administration of acetylstrophanthidin was deter- 
mined three consecutive times. Between each trial, 
the heart was washed with drug-free perfusion solu- 
tion for a period of 20 min. The fourth exposure to 
acetylstrophanthidin and the time to arrhythmia was 
done in the presence of potassium canrenoate added 
to the perfusion medium prior to the addition of ace- 
tylstrophanthidin and the latent period determined as 
before. 
In addition to demonstrating the ability of a com- 
pound to prevent the onset of the acetylstrophanthi- 
din arrhythmia, it was also possible to demonstrate 
the ability of a compound to suppress an already es- 
tablished arrhythmia. Once the acetylstrophanthidin- 
induced arrhythmia had been established, potassium 
canrenoate was added to the perfusion solution over a 
period of time to a maximum concentration of 
10 -3 M. 
2.3. Cat isolated papillary muscle preparations 
Cats of either sex, 1.5-2.0 kg were anesthetized 
with pentobarbital sodium given intraperitoneally in a 
dose of 30 mg/kg. The hearts were rapidly excised 
and placed in oxygenated, modified Krebs solution 
warmed to 37°C. Right ventricular papillary muscles 
were dissected free and mounted in muscle chambers 
containing 50 ml of modified Kreb's solution main- 
tained at 37°C and oxygenated with a mixture of 
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95% O2-5% COz ; the pH being 7.4. The non-tendi- 
nous ends of the muscles were attached in a Lucite 
clip and the upper end of the muscles were attached 
by braided non-capillary silk to a FT-03 force dis- 
placement transducer. The muscles were stretched by 
a resting force which was at the peak of their active 
length-tension curves and were maintained at this 
length throughout the study. The isometric muscles 
were stimulated via field electrodes with square-wave 
pulses of 0.5-msec duration at a rate of 12 min -1 with 
a current 10% above threshold delivered from a 104A 
American Electronics Laboratory Stimulator. All 
recordings were made on a Grass Model 7 Polygraph. 
The composition of the bath medium was as fol- 
lows, expressed as mM: Na ÷ 143, K ÷ 5.9, Ca 2. 2.5, 
Mg 2÷ 1.9, C1- 126, HzPO4- 1.19, dextrose 5. 
At the end of each experiment, the length of each 
muscle was determined, the muscles were weighed 
and their cross sectional area was calculated according 
to the formula: 
cross sectional area (mm 2) = mass (mg)/ 
spG (1.051 mg/mm 3) × length (mm) 
Data were expressed as force in g/mm 2 cross sectional 
area. Maximal developed force was determined by 
electrical paired pacing. The data were then expressed 
as a percentage of the maximal developed force. 
Statistical analysis of all data was done by using 
Student's t-test for paired comparisons (Snedecor, 
1956). 
The potassium and sodium salts of canrenoate 
used in this study were obtained from Dr. W. Scott 
Smith, Searle Laboratories, Chicago, Illinois. 
3. Results 
3.1. Effects o f  potassium canrenoate on ouabain- 
induced ventricular tachycardia 
Ouabain was administered to each of 8 dogs in an 
average dose of 64.4 +- 3.7/ag/kg, i.v., which resulted 
in a sustained ventricular tachycardia in each of the 
animals. The abnormal rhythm was allowed to con- 
tinue uninterrupted for at least 20min to insure 
against spontaneous reversal of the rapid ventricular 
ectopic rhythm. Stimulation of the distal end of the 
cut right vagus nerve failed to alter the ouabain- 
induced ectopic focus. Administration of potassium 
canrenoate, given i.v. as 3 injections of 10 mg/kg 
over a period of 20 min (total dose equal to 30 
mg/kg) failed to restore normal sinus rhythm in any 
of the animals. One of the 8 dogs which had received 
60/ag/kg of ouabain and had developed a multifocal 
ventricular tachycardia ultimately developed ventricu- 
lar fibrillation after receiving potassium canrenoate. 
Although normal sinus rhythm was not reestablished 
in any of the animals, there was the occurrence of a 
sino-atrial and/or'junctional tachycardia in 3 experi- 
ments one of which is shown in fig. 1. In each case, 
the rate of the sino-atrial or junctional tachycardia 
exceeded the rate of discharge of the ventricular ec- 
topic rhythm. Upon stimulation of the distal end of 
the right vagus nerve, however, the rate of the supra- 
ventricular rhythm slowed sufficiently so as to permit 
the ventricular focus to become the dominant 
rhythm. Stimulation of the vagus nerve in the remain- 
ing experiments was without effect on the ventricular 
ectopic focus which continued unaltered in spite of 
the administration of potassium canrenoate. The sub- 
sequent administration of propranolol (2.3 + 
0.1 mg/kg) to the 7 remaining animals restored nor- 
mal sinus rhythm in every instance. Furthermore, 
stimulation of the distal end of the right vagus nerve 
suppressed sino-atrial nodal pacemaker activity with- 
out unmasking ventricular pacemakers since propra- 
nolol has the ability, unlike potassium canrenoate, to 
suppress digitalis.induced automaticity. The adminis- 
tration of insulin (80 units, i.v.) restored ventricular 
tachycardia in each instance and served to demon- 
strate that ouabain was still present in a concentra- 
tion sufficient to induce disturbances in ventricular 
rhythm. The mechanism by which insulin causes a 
return of the ectopic focus involves the ability of the 
hormone to enhance cellular uptake of glucose which 
results in a decrease in plasma potassium. The result- 
ing hypokalemia intensifies the toxic effect of the 
digitalis glycoside. 
3.2. Effects o f  potassium canrenoate on acetylstro- 
phanthidin-induced arrhythmias 
5 rabbit isolated hearts were perfused by the Lan- 
gendorff method. Each heart was exposed to acetyl- 
strophanthidin, 640#g/1, 3 consecutive times for a 
total of 15 control determinations. The average 
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Fig. 1. Failure of potassium canrenoate to suppress the ouabain-induced ventricular ectopic focus in the canine heart. Each panel 
shows the arterial blood pressure and the Lead II electrocardiogram. The upper central panel is a control tracing illustrating the 
ability of right vagal stimulation to suppress the supraventricular pacemaker. The center left hand panel shows the effects of a 
toxic dose of ouabain. The ouabain-induced ventriculat tachycardia is not influenced by stimulation of the right vagus. The 
ventricular rate is 234 beats/min. After the administration of potassium canmnoatc (30 mg/kg, i.v.), there is an abrupt change in 
the electrocardiogram from that of a ventricula.r tachycardia to that of a sino-atrial tachycardia with a rate of 240 beats/min. 
Stimulation of the right vagus nerve, however, unmasks the ouabain-induced ventricular ectopic focus (rate 225 beats/rain). The 
lower left hand panel shows the effects of propranolol in terminating the digitalis-induced arrhythmia and a complete suppression 
of the ectopic focus as evidenced by the suppression of all pacemaker activity during vagal stimulation. The lower right hand 
panel shows a return of the ventricular ectopic pacemaker after the administration of insulin. 
' latent period' before the onset of the arrhythmia was 
185.6 ± 18.8 (S.E.M.) sec. When the hearts were si- 
multaneously perfused with a medium containing 
potassium canrenoate, 10 -a M and acetylstrophanthi- 
din, 640/~g/1, the time to arrhythmia averaged 191.8 
± 37.5 sec and was not significantly different from 
control (p> 0.5). Thus, potassium canrenoate did not 
prevent the development of acetylstrophanthidin- 
induced toxicity in the rabbit isolated heart. 
In a separate series of 5 rabbit isolated hearts, ar- 
rhythmias were produced by exposing the prepara- 
tions to acetylstrophanthidin, 640 #g/l. When the ar- 
rhythmia had been established, potassium canrenoate 
was added to the perfusion solution in concentrations 
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Fig. 2. The inability of potassium canrenoate to reverse the acetylstrophanthidin-induced arrhythmia in the rabbit isolated heart. 
Panel A is a control electrocardiogram. Panel B shows a multifocal ventricular tachycardia 8 min after acetylstrophanthidin was 
added to the perfusion medium. Panel C was taken 3 min after the addition of potassium canrenoate (10 -s M) and Panel D was 
made 3 min after the concentration of potassium canrenoate was increased to 10 -4 M. As illustrated in the final tracing, the 
multifocal ventricular arrhythmia finally terminated in ventricular fibrillation. 
of 10 -s M, 1 0 - 4 M  and 10-aM with each addition 
being made at 3-min intervals. In no instance was 
there a return to normal sinus rhythm. Fig. 2 illus- 
trates the sequence of events from one experiment  in 
which ventricular fibrillation developed 3 min after 
potassium canrenoate, 10 -4 M had been added to the 
perfusion medium. In the remaining 4 hearts, potas- 
sium canrenoate, 10 -a M, did not alter the acetyl- 
strophanthidin-induced arrhythmia which progressed 
in each case to a multifocal ventricular tachycardia 
and ventricular fibrillation. 
3. 3. E / fec t  o f  sodium canrenoate on cat isolated pap- 
illary muscles 
The sodium salt of  canrenoate was used in this 
part of  the study to circumvent the effects of  the 
potassium ion upon developed isometric force. A 
total of  6 cat isolated papillary muscles was exposed 
to sodium canrenoate in concentrations of 10 -6 to 
10 -3 M. Control isometric force averaged 61.2% + 6.0 
(S.E.M.) of the developed maximal force in response 
to paired pacing. Significant depression in isometric 
force was apparent at a sodium canrenoate concentra- 
tion of 10 -4 M. At this concentration, developed iso- 
metric tension averaged 49..7% + 5.5 of  maximal iso- 
metric force (p<  0.001) with a further depression in 
contracti l i ty occurring at 10 -a M sodium canrenoate 
where isometric force averaged 21.5% +- 2.8 of  the 
maximal isometric force (p<  0.001). The subsequent 
addition of  ouabain (1.02 X 10 -6 M) in the presence 
of 10-aM sodium canrenoate resulted in a positive 
inotropic effect which averaged 60.7% -+ 7.4 of  the 
maximal developed isometric tension. Thus, sodium 
canrenoate produces a significant negative inotropic 
effect in cat isolated papillary muscles. Furthermore,  
the digitalis glycoside, ouabain, is capable of  reversing 
the negative inotropic action of sodium canrenoate 
which would suggest that the latter does not antago- 
nize or prevent the positive inotropic effects of  digita- 
lis. It was of  further interest, that 5 of  the 6 papillary 
muscles exposed to ouabain (1.02 X 10 -6 M) and so- 
dium canrenoate (10 -a M) ult imately developed signs 
of toxici ty as evidenced by the development of  auto- 
maticity. Thus, as in the previous studies in the intact 
canine heart and in the rabbit  isolated heart, digitalis- 
induced toxici ty could not be prevented by the potas- 
sium or sodium salts of  canrenoate. 
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4. Discussion 
The present investigation dealing with the ability 
of potassium canrenoate to antagonize digitalis- 
induced arrhythmias has led to a conclusion that is in 
disagreement with that of Yeh et al. (1971), Yeh et 
al. (1972) and Yeh and Sung (1972). The previous 
studies had suggested that potassium canrenoate was 
an antagonist to the cardiotoxic actions of ouabain 
and possessed an 'all or none' effect (Yeh and Sung, 
1972) as evidenced by the fact that 6 of the 11 oua- 
bain-intoxicated animals were successfully converted. 
Reference to fig. 3 in the publication by Yeh and 
Sung (1972) may provide an answer to the discrep- 
ancy between their results and those obtained in the 
present study. It will be noted that the rate of the 
ventricular ectopic focus decreased from 200 to 190 
per rain soon after the administration of potassium 
canrenoate. The conversion to normal sinus rhythm 
which followed was at a rate of 200 per min, a rate 
which now exceeded that of the ventricular ectopic 
focus and thus became the dominant rhythm. A simi- 
lar phenomenon was seen in the present investigation 
and is illustrated in fig. 1. The development of a sino- 
atrial or junctional rhythm with a rate in excess of 
the ventricular ectopic focus tended to mask the un- 
derlying ouabain-induced automaticity. Stimulation 
of the vagus nerve, however, which is capable of de- 
creasing the rate of S -A  nodal and junctional 
rhythms permits the ventricular ectopic focus to be- 
come the dominant pacemaker. The present studies 
demonstrate that potassium canrenoate does not have 
the ability to suppress digitalis-induced automaticity 
in the intact dog heart and the 'all or none' effect 
reported by Yeh and Sung (1972) might be related to 
a masking of the ventricular ectopic focus by a supra- 
ventricular pacemaker with a faster fate of discharge. 
The results obtained with propranolol in the present 
study illustrate the importance of slowing the supra- 
ventricular pacemaker in order to demonstrate that 
the antiarrhythmic agent is capable of suppressing the 
ouabain-induced ectopic focus and that the conver- 
sion is not due to overdrive suppression of the ven- 
tricular pacemaker. 
Studies in the isolated heart are in agreement with 
those in the intact canine heart. The acetylstrophan- 
thidin-induced arrhythmia in the rabbit Langendorff 
heart preparation has been used successfully in this 
laboratory to evaluate the antiarrhythmic activity of 
several agents (Lucchesi and Hardman, 1961 ; Lucchesi, 
1965; Lucchesi and lwami, 1968) and has provided 
good correlation with in vivo results. The same corre- 
lation between in vivo and in vitro results exists with 
respect to the observations made with potassium can- 
renoate. The drug failed to prevent or delay the ap- 
pearance of the acetylstrophanthidin-induced ar- 
rhythmia in the rabbit isolated heart. Furthermore, 
once an arrhythmia had been established, potassium 
canrenoate was unable to abolish the cardiotoxic ef- 
fects of acetylstrophanthidin. In addition, the sodium 
salt of canrenoate produced a marked negative ino- 
tropic effect in cat isolated papillary muscles. The 
depressant effect of sodium canrenoate was reversed 
by ouabain, further demonstrating that canrenoate 
lacks a specific antagonistic action to the effects of 
digitalis as suggested by Yeh and Lazzara (197 I). Yet 
to be resolved is the fact that Yeh and Lazzara (1971) 
have noted that potassium canrenoate restored the 
resting, membrane potential, action potential over- 
shoot, dV/dt, and excitability in digitalis-poisoned 
Purkinje fibers. Whether or not this effect is specific 
for digitalis-induced alterations in the membrane 
action potential remains to be determined. In addi- 
tion the recently reported observation by Yeh et al. 
(1972), that potassium canrenoate improves atrioven- 
tricular transmission in the digitalis-intoxicated heart 
could also provide an explanation for the apparent 
ability of the drug to restore normal sinus rhtyhm in 
the digitalis-intoxicated heart. 
The results of these studies lead to the conclusion 
that potassium canrenoate, a specific antagonist of 
aldosterone, lacks specific antiarrhythmic activity 
against digitalis-induced arrhythmias. 
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